September 22, 2014 2:33 PM ET

Biotechnology

Company Overview of OvaScience, Inc.

Company Overview

OvaScience, Inc., a life sciences company, is engaged in the discovery, development, and commercialization of new treatments for infertility. The company’s patented technology is based on the discovery of egg precursor cells (EggPCs), which are found in the ovaries. It is developing various fertility treatment options designed to enhance egg quality and in vitro fertilization (IVF) comprising AUGMENT to improve egg quality and increase the success of IVF by transferring mitochondria from a woman's EggPCs to her mature egg during IVF; OvaPrime for boosting a woman's egg reserve by transferring the EggPCs from the outer layer of her ovary back into the ovary prior to IVF; OvaTure to create mat...

215 First Street

Suite 240

Cambridge, MA 02142

United States

Founded in 2011

28 Employees

Phone:

617-500-2802

Key Executives for OvaScience, Inc.

Co-Founder
Age: 38
Chief Commercial Officer and Head of Sales & Marketing
Age: 57
Total Annual Compensation: $310.0K
Chief Scientific Officer
Total Annual Compensation: $106.3K
Compensation as of Fiscal Year 2013.

OvaScience, Inc. Key Developments

OvaScience Appoints Jeffrey Young as Chief Financial Officer

OvaScience announced the appointment of Jeffrey Young to Chief Financial Officer. Mr. Young joins OvaScience from Transmedics, Inc., where he served as Chief Financial Officer and Treasurer, leading the finance, accounting, tax and treasury functions. Prior to serving as CFO of Transmedics, Mr. Young was CFO and Treasurer at Lantheus Medical Imaging, Inc. While at Lantheus, an international corporation, he was responsible for multiple functions, including finance, accounting, customer service, tax and treasury.

OvaScience, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

OvaScience, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported loss from operations was of $9.595 million compared to $6.021 million a year ago. Net loss applicable to common stockholders was of $9.893 million or $0.42 per basic and diluted share compared to $5.996 million or $0.36 per basic and diluted share a year ago. For six months, the company reported loss from operations was of $17.245 million compared to $11.196 million a year ago. Net loss applicable to common stockholders was of $17.707 million or $0.83 per basic and diluted share compared to $11.153 million or $0.74 per basic and diluted share a year ago.

OvaScience, Inc. Presents at Wedbush 2014 Life Sciences Management Access Conference, Aug-13-2014 08:35 AM

OvaScience, Inc. Presents at Wedbush 2014 Life Sciences Management Access Conference, Aug-13-2014 08:35 AM. Venue: Le Parker Meridien, New York, New York, United States.

Similar Private Companies By Industry

Company Name Region
Neurop, Inc. United States
Applied Veterinary Systems United States
Rubicon Genomics, Inc. United States
StemBioSys, Inc. United States
Asahi Kasei Technikrom, Inc United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OvaScience, Inc., please visit www.ovascience.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.